# EDGAR Filing Document

**Accession Number:** 0001892770
**File Stem:** 0001104659-25-085240
**Filing Date:** 2025-8
**Character Count:** 45041
**Document Hash:** 7dea8ba51259cf4fa399b78ed7c53a08
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-085240.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001104659-25-085240

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Knott David M Jr
- **CENTRAL INDEX KEY:** 0001892770

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-21815
- **FILM NUMBER:** 251276605

**MAIL ADDRESS:**
- **STREET 1:** DORSET MANAGEMENT CORPORATION
- **STREET 2:** 485 UNDERHILL BOULEVARD, SUITE 205
- **CITY:** SYOSSET
- **STATE:** NY
- **ZIP:** 11791

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001892770

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Knott David M Jr

**Address:** 485 Underhill Blvd, Syosset, NY 11791-3419

**Telephone number:** 516-364-0303

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 28-21815

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 1

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                      | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                           | VOTE CATEGORY                |     SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Leap Therapeutics, Inc.             | 52187K200 | 07/02/2024     | Advisory vote on executive compensation paid to named executive officers ("Say-on-Pay Proposal").                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES | 114355           |                0 | FOR         |                         114355           | FOR                         |  |
| Avadel Pharmaceuticals Plc          | G29687103 | 07/30/2024     | To approve, on a non-binding advisory basis, the compensation of the named executive officers of the Company                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES | 333000           |                0 | FOR         |                         333000           | FOR                         |  |
| Immunovant, Inc.                    | 45258J102 | 08/12/2024     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |  87815           |                0 | FOR         |                          87815           | FOR                         |  |
| Roivant Sciences Ltd.               | G76279101 | 09/10/2024     | To cast a non-binding, advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |  62982           |                0 | FOR         |                          62982           | FOR                         |  |
| Roivant Sciences Ltd.               | G76279101 | 09/10/2024     | To cast a non-binding, advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers every:                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |  62982           |                0 | ONE YEAR    |                          62982           | FOR                         |  |
| Enstar Group Limited                | G3075P101 | 11/06/2024     | To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Enstar to its named executive officers in connection with the Mergers.                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |   7500           |                0 | AGAINST     |                           7500           | AGAINST                     |  |
| Microsoft Corp                      | 594918104 | 12/10/2024     | Advisory Vote to Approve Named Executive Officer Compensation ("say-on-pay vote")                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |   1800           |                0 | FOR         |                           1800           | FOR                         |  |
| Legacy Housing Corp                 | 52472m101 | 12/28/2024     | For or against a resolution approving the compensation paid to the Company's named executive officers. This is a non-binding advisory vote and is referred to as a "Say on Pay" vote;                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |   4000           |                0 | FOR         |                           4000           | FOR                         |  |
| Apple Inc                           | 037833100 | 02/25/2025     | Advisory Vote to Approve Executive Compensation                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |   2100           |                0 | FOR         |                           2100           | FOR                         |  |
| Dow Inc.                            | 260557103 | 04/10/2025     | Advisory Resolution to Approve Executive Compensation                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |   1206           |                0 | FOR         |                           1206           | FOR                         |  |
| Broadcom Inc.                       | 11135F101 | 04/21/2025     | To hold an advisory vote to approve the named executive officer compensation.                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |    710           |                0 | FOR         |                            710           | FOR                         |  |
| Pfizer Inc.                         | 717081103 | 04/24/2025     | 2025 advisory approval of executive compensation                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES | 170000           |                0 | AGAINST     |                         170000           | AGAINST                     |  |
| Verona Pharma Plc                   | 925050106 | 04/24/2025     | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES | 112900           |                0 | AGAINST     |                         112900           | AGAINST                     |  |
| Johnson                             | 478160104 | 04/24/2025     | Vote, on an advisory basis, to approve named executive officer compensation.                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |   2766           |                0 | FOR         |                           2766           | FOR                         |  |
| Pfizer Inc.                         | 717081103 | 04/24/2025     | To conduct an advisory vote to approve our executive compensation.                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |     80           |                0 | FOR         |                             80           | FOR                         |  |
| Coca-Cola Co.                       | 191216100 | 04/30/2025     | Conduct an advisory vote to approve executive compensation.                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |   2000           |                0 | FOR         |                           2000           | FOR                         |  |
| Corteva Inc.                        | 22052L104 | 04/30/2025     | Advisory resolution to approve the compensation of the Company's named executive officers.                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |  11051           |                0 | FOR         |                          11051           | FOR                         |  |
| aTyr Pharma, Inc.                   | 002120202 | 05/01/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers;                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES | 308133           |                0 | FOR         |                         308133           | FOR                         |  |
| Kimberly- Clark Corp                | 494368103 | 05/01/2025     | Approve the compensation for our named executive officers in an advisory vote                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |   6000           |                0 | FOR         |                           6000           | FOR                         |  |
| Starwood Property Trust             | 85571B105 | 05/01/2025     | Approve on an advisory basis the Company's executive compensation                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |    400           |                0 | FOR         |                            400           | FOR                         |  |
| Occidental Petroleum Corp           | 674599105 | 05/02/2025     | Approve, on an advisory basis, named executive officer compensation                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |    469           |                0 | FOR         |                            469           | FOR                         |  |
| Eli Lilly  Co                       | 532457108 | 05/05/2025     | Approval, on an advisory basis, of the compensation paid to the company's named executive officers                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |    300           |                0 | FOR         |                            300           | FOR                         |  |
| Bristol-Myers Squibb Company        | 110122108 | 05/06/2025     | Advisory Vote to Approve the Compensation of our Named Executive Officers                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |  15000           |                0 | FOR         |                          15000           | FOR                         |  |
| CSX Corporation                     | 126408103 | 05/07/2025     | Advisory (non-binding) resolution to approve compensation for the Company's named executive officers.                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |  70000           |                0 | FOR         |                          70000           | FOR                         |  |
| Ryman Hospitality Properties        | 78377t107 | 05/08/2025     | To approve, on an advisory basis, our executive compensation;                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |  12000           |                0 | FOR         |                          12000           | FOR                         |  |
| United Rentals Inc                  | 911363109 | 05/08/2025     | To approve our executive compensation on an advisory basis;                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |     78           |                0 | FOR         |                             78           | FOR                         |  |
| AbbVie Inc                          | 00287y109 | 05/09/2025     | To vote on an advisory basis on the approval of executive compensation.                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |   5037           |                0 | FOR         |                           5037           | FOR                         |  |
| Mereo BioPharma Group Plc           | 589492107 | 05/13/2025     | That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES | 319337           |                0 | FOR         |                         319337           | FOR                         |  |
| Mereo BioPharma Group Plc           | 589492107 | 05/13/2025     | That the frequency of future advisory votes on the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES | 319337           |                0 | ONE YEAR    |                         319337           | AGAINST                     |  |
| International Gaming Tech           | 459902102 | 05/13/2025     | That the directors' remuneration report (excluding the part containing the directors' remuneration policy) That the directors' remuneration report (excluding the part containing the directors' remuneration policy) for the financial year ended 31 December 2024 set out in the Annual Report and Accounts be approved. | SECTION 14A SAY-ON-PAY VOTES |   5500           |                0 | FOR         |                           5500           | FOR                         |  |
| Syndax Pharmaceuticals, Inc.        | 87164F105 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement.                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES | 128000           |                0 | FOR         |                         128000           | FOR                         |  |
| Vera Therapeutics, Inc.             | 92337R101 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |  10000           |                0 | FOR         |                          10000           | FOR                         |  |
| Vera Therapeutics, Inc.             | 92337R101 | 05/14/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |  10000           |                0 | ONE YEAR    |                          10000           | FOR                         |  |
| Collegium Pharmaceutical, Inc.      | 19459J104 | 05/15/2025     | Approval of, on an advisory basis, the compensation of the Company's named executive officers                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |  38473           |                0 | FOR         |                          38473           | FOR                         |  |
| Collegium Pharmaceutical, Inc.      | 19459J104 | 05/15/2025     | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |  38473           |                0 | ONE YEAR    |                          38473           | FOR                         |  |
| Travere Therapeutics, Inc.          | 89422G107 | 05/15/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES | 228000           |                0 | FOR         |                         228000           | FOR                         |  |
| Ultragenyx Pharmaceutical Inc.      | 90400D108 | 05/15/2025     | Advisory (non-binding) vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |  48000           |                0 | AGAINST     |                          48000           | AGAINST                     |  |
| Wabtec Corp                         | 929740108 | 05/15/2025     | Approve an advisory (non-binding) resolution to approve the 2024 named executive officer compensation                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |      6           |                0 | FOR         |                              6           | FOR                         |  |
| AtriCure, Inc.                      | 04963C209 | 05/19/2025     | Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting.                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |  19620           |                0 | FOR         |                          19620           | FOR                         |  |
| AtriCure, Inc.                      | 04963C209 | 05/19/2025     | Advisory vote on the frequency of future advisory votes on compensation of our named executive officers.                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |  19620           |                0 | ONE YEAR    |                          19620           | FOR                         |  |
| Eastern Bancshares Inc              | 27627n105 | 05/19/2025     | to hold an advisory vote on executive compensation;                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |   5000           |                0 | FOR         |                           5000           | FOR                         |  |
| Catalyst Pharmaceuticals, Inc.      | 14888U101 | 05/20/2025     | To approve, on an advisory basis, the 2024 compensation of our named executive officers.                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES | 212000           |                0 | FOR         |                         212000           | FOR                         |  |
| JP Morgan Chase  Co                 | 46625H100 | 05/20/2025     | Advisory resolution to approve executive compensation                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |  26185           |                0 | FOR         |                          26185           | FOR                         |  |
| Amazon                              | 023135106 | 05/21/2025     | Advisory vote to approve executive compensation                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |    900           |                0 | FOR         |                            900           | FOR                         |  |
| Mondelez Intl                       | 609207105 | 05/21/2025     | To approve, on an advisory basis, the Company's executive compensation                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |  10000           |                0 | FOR         |                          10000           | FOR                         |  |
| Thermo FisherScientific Inc         | 883556102 | 05/21/2025     | Approval of an advisory vote on executive compensation                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |     45           |                0 | FOR         |                             45           | FOR                         |  |
| Dupont De Nemours Inc               | 26614n102 | 05/22/2025     | Advisory resolution to approve executive compensation.                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |   9418           |                0 | FOR         |                           9418           | FOR                         |  |
| FS Bancorp Inc                      | 30263Y104 | 05/22/2025     | Advisory (non-binding) approval of the compensation of our named executive officers as disclosed in this proxy statement.                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |   2274           |                0 | FOR         |                           2274           | FOR                         |  |
| FS Bancorp Inc                      | 30263Y104 | 05/22/2025     | Advisory (non-binding) vote on whether future advisory votes on executive compensation should be held every one, two or three years.                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |   2274           |                0 | ONE YEAR    |                           2274           | FOR                         |  |
| Quanta Services                     | 74762e102 | 05/22/2025     | Approval, by non-binding advisory vote, of Quanta's executive compensation;                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |    176           |                0 | FOR         |                            176           | FOR                         |  |
| TotalEnergies SE                    | 89151e109 | 05/23/2025     | Approval of the information relating to the compensation of executive and non-executive directors ("mandataires sociaux") mentioned in paragraph I of Article L. 22-10-9 of the FrenchCommercial Code                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |   1200           |                0 | FOR         |                           1200           | FOR                         |  |
| TotalEnergies SE                    | 89151e109 | 05/23/2025     | Setting of the amount of directors' aggregate annual compensation and approval of the compensation policy of directors                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |   1200           |                0 | FOR         |                           1200           | FOR                         |  |
| TotalEnergies SE                    | 89151e109 | 05/23/2025     | Approval of the fixed, variable and extrodanary components making up the total compensation of the chariman and CEO                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |   1200           |                0 | FOR         |                           1200           | FOR                         |  |
| TotalEnergies SE                    | 89151e109 | 05/23/2025     | Approval of the compensation policy applicable to the Chairman and CEO                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |   1200           |                0 | FOR         |                           1200           | FOR                         |  |
| Arcellx, Inc.                       | 03940C100 | 05/28/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |  15000           |                0 | FOR         |                          15000           | FOR                         |  |
| Ge Healthcare Technology            | 36266g107 | 05/28/2025     | Approval of Our Named Executive Officers' Compensation in an Advisory Vote                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |     50           |                0 | FOR         |                             50           | FOR                         |  |
| Internationa Business Machines Corp | 459200101 | 05/29/2025     | Advisory vote on executive compensation.                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |   2142           |                0 | FOR         |                           2142           | FOR                         |  |
| United Healthcare Group             | 91324p102 | 06/02/2025     | Conduct an advisory vote to approve the compensation paid to the Company's named executive officers as disclosed in the attached proxy statement                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |     57           |                0 | FOR         |                             57           | FOR                         |  |
| Cogent Biosciences, Inc.            | 19240Q201 | 06/04/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES | 269163           |                0 | FOR         |                         269163           | FOR                         |  |
| Xenon Pharmaceuticals Inc.          | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers;                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |  15866           |                0 | FOR         |                          15866           | FOR                         |  |
| Xeris Biopharma Holdings, Inc.      | 98422E103 | 06/04/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |      1.06e+06    |                0 | FOR         |                              1.06e+06    | FOR                         |  |
| Myriad Genetics, Inc.               | 62855J104 | 06/05/2025     | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES | 160000           |                0 | FOR         |                         160000           | FOR                         |  |
| Salesforce Inc.                     | 79466l302 | 06/05/2025     | To approve, on an advisory basis, the fiscal 2025 compensation of our named executive officers.                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |     77           |                0 | FOR         |                             77           | FOR                         |  |
| Tectonic Therapeutic, Inc.          | 878972108 | 06/06/2025     | Advisory approval of the compensation of the Company's Named Executive Officers.                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |  60000           |                0 | FOR         |                          60000           | FOR                         |  |
| Tectonic Therapeutic, Inc.          | 878972108 | 06/06/2025     | Advisory vote on the frequency of stockholder advisory votes on executive compensation.                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |  60000           |                0 | ONE YEAR    |                          60000           | FOR                         |  |
| Arcus Biosciences, Inc.             | 03969F109 | 06/10/2025     | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement.                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |  39000           |                0 | FOR         |                          39000           | FOR                         |  |
| Calumet, Inc.                       | 131428104 | 06/10/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |      1.16647e+06 |                0 | FOR         |                              1.16647e+06 | FOR                         |  |
| Calumet, Inc.                       | 131428104 | 06/10/2025     | To vote, on a non-binding, advisory basis, on the frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers.                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |      1.16647e+06 |                0 | ONE YEAR    |                              1.16647e+06 | FOR                         |  |
| BioCryst Pharmaceuticals, Inc.      | 09058V103 | 06/12/2025     | To hold a non-binding, advisory vote regarding executive compensation.                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES | 460000           |                0 | FOR         |                         460000           | FOR                         |  |
| Solid Biosciences Inc.              | 83422E204 | 06/12/2025     | The approval of an advisory vote on executive compensation.                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES | 132000           |                0 | AGAINST     |                         132000           | AGAINST                     |  |
| DocGo Inc.                          | 256086109 | 06/17/2025     | To approve on a non-binding, advisory basis the compensation of the Company's named executive officers.                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |      3.07085e+06 |                0 | AGAINST     |                              3.07085e+06 | AGAINST                     |  |
| Ardelyx, Inc.                       | 039697107 | 06/18/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay");                                                        | SECTION 14A SAY-ON-PAY VOTES | 449807           |                0 | FOR         |                         449807           | FOR                         |  |
| BridgeBio Pharma, Inc.              | 10806X102 | 06/20/2025     | To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers.                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |  22000           |                0 | AGAINST     |                          22000           | AGAINST                     |  |
| Protagonist Therapeutics, Inc.      | 74366E102 | 06/20/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |  80000           |                0 | FOR         |                          80000           | FOR                         |  |
| Viridian Therapeutics, Inc.         | 92790C104 | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |  30000           |                0 | AGAINST     |                          30000           | AGAINST                     |  |
| NVDIA Corp                          | 67066G104 | 06/25/2025     | Advisory approval of our executive compensation                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |   2560           |                0 | FOR         |                           2560           | FOR                         |  |
| Kyndryl Holdings                    | 50155Q100 | 07/31/2025     | Approval, in an advisory, non-binding vote, of the compensation of our named executive officers                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |    428           |                0 | FOR         |                            428           | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Knott David M Jr

**By (Signature):** /s/ David M. Knott Jr

**By (Printed Signature):** /s/ David M. Knott Jr

**By (Title):** Investment Manager

**Date:** 08/29/2025